Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Hironobu Tsukada, Ph.D.
Director
Sumitomo Pharma Co Ltd, Japan
Poster(s):
027: Application of Modeling & Simulation to Quantitatively Assess Ulotaront Metabolism & the Effect of a CYP450 Inhibitor in Healthy Subjects
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT